{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:34:14Z","timestamp":1779204854345,"version":"3.51.4"},"reference-count":23,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA037773\u201001A1"],"award-info":[{"award-number":["R01 DA037773\u201001A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008673","name":"Center for AIDS Research, University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI036214"],"award-info":[{"award-number":["P30 AI036214"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Prisoners are a priority group for hepatitis C (HCV) treatment. Although treatment durations will become shorter using directly acting antivirals (DAAs), nearly half of prison sentences in Scotland are too short to allow completion of DAA therapy prior to release. The purpose of this study was to compare treatment outcomes between prison\u2010 and community\u2010based patients and to examine the impact of prison release or transfer during therapy. A national database was used to compare treatment outcomes between prison treatment initiates and a matched community sample. Additional data were collected to investigate the impact of release or transfer on treatment outcomes. Treatment\u2010na\u00efve patients infected with genotype 1\/2\/3\/4 and treated between 2009 and 2012 were eligible for inclusion. 291 prison initiates were matched with 1137 community initiates: SVRs were 61% (95% CI 55%\u201366%) and 63% (95% CI 60%\u201366%), respectively. Odds of achieving a SVR were not significantly associated with prisoner status (<jats:italic>P<\/jats:italic>=.33). SVRs were 74% (95% CI 65%\u201381%), 59% (95% CI 42%\u201375%) and 45% (95% CI 29%\u201362%) among those not released or transferred, transferred during treatment, or released during treatment, respectively. Odds of achieving a SVR were significantly associated with release (<jats:italic>P<\/jats:italic>&lt;.01), but not transfer (<jats:italic>P<\/jats:italic>=.18). Prison\u2010based HCV treatment achieves similar outcomes to community\u2010based treatment, with those not released or transferred during treatment doing particularly well. Transfer or release during therapy should be avoided whenever possible, using anticipatory planning and medical holds where appropriate.<\/jats:p>","DOI":"10.1111\/jvh.12580","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T09:02:52Z","timestamp":1470906172000},"page":"1009-1016","source":"Crossref","is-referenced-by-count":45,"title":["A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy"],"prefix":"10.1111","volume":"23","author":[{"given":"E. J.","family":"Aspinall","sequence":"first","affiliation":[{"name":"School of Health and Life Sciences Glasgow Caledonian University  Glasgow UK"},{"name":"Health Protection Scotland NHS National Services Scotland  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"NHS Forth Valley Viral Hepatitis Service  Stirling UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schofield","sequence":"additional","affiliation":[{"name":"Public Health Protection Unit NHS Greater Glasgow and Clyde  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cairns","sequence":"additional","affiliation":[{"name":"Western General Hospital  Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lamond","sequence":"additional","affiliation":[{"name":"Western General Hospital  Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bramley","sequence":"additional","affiliation":[{"name":"NHS Forth Valley Viral Hepatitis Service  Stirling UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. E.","family":"Peters","sequence":"additional","affiliation":[{"name":"Gartnavel General Hospital  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Valerio","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences Glasgow Caledonian University  Glasgow UK"},{"name":"Health Protection Scotland NHS National Services Scotland  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tomnay","sequence":"additional","affiliation":[{"name":"Crosshouse Hospital  Kilmarnock UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences Glasgow Caledonian University  Glasgow UK"},{"name":"Health Protection Scotland NHS National Services Scotland  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Mills","sequence":"additional","affiliation":[{"name":"Gartnavel General Hospital  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. T.","family":"Barclay","sequence":"additional","affiliation":[{"name":"Walton Liver Clinic Glasgow Royal Infirmary NHS Greater Glasgow and Clyde  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fraser","sequence":"additional","affiliation":[{"name":"Aberdeen Royal Infirmary NHS Grampian  Aberdeen UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"Dillon","sequence":"additional","affiliation":[{"name":"Ninewells Hospital and Medical School NHS Tayside  Dundee UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. K.","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Global Public Health University of California San Diego  San Diego CA USA"},{"name":"School of Social and Community Medicine University of Bristol  Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hickman","sequence":"additional","affiliation":[{"name":"School of Social and Community Medicine University of Bristol  Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Hutchinson","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences Glasgow Caledonian University  Glasgow UK"},{"name":"Health Protection Scotland NHS National Services Scotland  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01934.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26387"},{"key":"e_1_2_8_4_1","unstructured":"WalmsleyR.World Prison Population List (tenth edition). International Centre for Prison Studies. International Centre for Prison Studies 2013.http:\/\/prisonstudies.org\/sites\/prisonstudies.org\/files\/resources\/downloads\/wppl_10.pdf\/. Accessed June 2 2015."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.143"},{"key":"e_1_2_8_6_1","unstructured":"European Association for the Study of Liver Diseases.EASL Clinical Practice Guidelines 2015."},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12107"},{"key":"e_1_2_8_8_1","unstructured":"University of the West of Scotland Health Protection Scotland University of Strathclyde and the West of Scotland Specialist Virology Centre.The Needle Exchange Surveillance Initiative (NESI): prevalence of HCV and injecting risk behaviours among people who inject drugs attending injecting equipment provision services in Scotland 2008\/2009 & 2010. University of the West of Scotland September 2012."},{"key":"e_1_2_8_9_1","unstructured":"Scottish Government.Hepatitis C Action Plan for Scotland: Phase II: May 2008\u2013March 2011. Scottish Government 2008.http:\/\/www.scotland.gov.uk\/Resource\/Doc\/222750\/0059978.pdf. Accessed October 27 2014."},{"key":"e_1_2_8_10_1","unstructured":"Public Health England.Hepatitis C in the UK: 2014 Report.https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/337115\/HCV_in_the_UK_2014_24_July.pdf. Accessed 18 June 2014."},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25770"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7085"},{"key":"e_1_2_8_13_1","unstructured":"Scottish Government.Statistical Bulletin Crime and Justice Series: Prison Statistics Scotland: 2012\u201313.http:\/\/www.gov.scot\/Topics\/Statistics\/Browse\/CrimeJustice\/Datasets\/PrisonsDatasets\/prisdata1213. Accessed September 30 2015."},{"key":"e_1_2_8_14_1","unstructured":"Audit Scotland.Managing increasing prisoner numbers in Scotland. Audit Scotland May 2008.http:\/\/www.audit-scotland.gov.uk\/docs\/central\/2008\/nr_080508_prisoner_numbers.pdf. Accessed June 8 2015."},{"key":"e_1_2_8_15_1","unstructured":"Scottish Government.The Sexual Health and Blood Borne Virus Framework 2011\u201315.http:\/\/www.gov.scot\/Resource\/Doc\/356286\/0120395.pdf. Accessed June 1 2015."},{"key":"e_1_2_8_16_1","unstructured":"Healthcare Improvement Scotland.Quality Indicators for Hepatitis C April 2012.http:\/\/www.healthcareimprovementscotland.org\/our_work\/long_term_conditions\/hepatitis_c\/hepatitis_c_quality_indicators.aspx. Accessed May 5 2015."},{"key":"e_1_2_8_17_1","unstructured":"Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis Hepatitis C Subcommittee.Hepatitis C Prevention Treatment and Care: Guidelines for Australian Custodial Settings 2008.http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/DA9F4D3AA93288EFCA257BF00021DF13\/$File\/prison-guidelines.pdf. Accessed August 12 2015."},{"key":"e_1_2_8_18_1","unstructured":"American Association for the Study of Liver Diseases.Recommendations for Testing Managing and Treating Hepatitis C."},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.05.015"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003153"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28497"},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","unstructured":"HumphreysC LombardM NewtonA O'MooreE RailtonC.An audit of hepatitis C services in a representative sample of English prisons. Public Health England and Department of Health 2013.https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/337401\/An_audit_of_hepatitis_C_services_in_a_representative_sample_of_English_prisons_2013.pdf. Accessed July 21 2015.","DOI":"10.1016\/S0140-6736(13)62474-5"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2008.01055.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.008"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12580","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12580","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:18:00Z","timestamp":1696220280000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1111\/jvh.12580"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12580","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]}}}